TgPVR21 mice for testing type-3 oral poliovirus vaccines: role of clinical observation and histological examination

Author： Dragunsky E. Chernokhvostova Y. Taffs R. Chumakov K. Gardner D. Asher D. Nomura T. Hioki K. Levenbook I.

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.15, Iss.17, 1997-12, pp. : 1863-1866

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison of neuropathogenicity of poliovirus type 3 in transgenic mice bearing the poliovirus receptor gene and cynomolgus monkeys

By Nagata N. Iwasaki T. Ami Y. Harashima A. Hatano I. Suzaki Y. Yoshii K. Yoshii T. Nomoto A. Kurata T.

Vaccine, Vol. 19, Iss. 23, 2001-04 ,pp. : 3201-3208

Elsevier

Access to resources Recommend Favorite

New approaches to oral poliovirus vaccine neurovirulence tests: transgenic mice susceptible to poliovirus and molecular analysis of poliovirus

By Wood D.J.

Vaccine, Vol. 15, Iss. 4, 1997-03 ,pp. : 341-345

Elsevier

Access to resources Recommend Favorite

Serological response and poliovirus excretion following different combined oral and inactivated poliovirus vaccines immunization schedules

By du Chatelet I.P. Merchant A.T. Fisher-Hoch S. Luby S.P. Plotkin S.A. Moatter T. Agboatwalla M. Mc Cormick J.B.

Vaccine, Vol. 21, Iss. 15, 2003-04 ,pp. : 1710-1718

Elsevier

Access to resources Recommend Favorite

Immunogenicity of a pilot inactivated poliovirus vaccine with trypsin-treated type 3-component

By Piirainen L. Roivainen M. Litmanen L. Eskola J. Beuvery E.C. Hovi T.

Vaccine, Vol. 15, Iss. 2, 1997-02 ,pp. : 237-243

Elsevier

Access to resources Recommend Favorite

Microparticles for oral delivery of vaccines

By Mutwiri George Bowersock Terry L Babiuk Lorne A

Expert Opinion on Drug Delivery, Vol. 2, Iss. 5, 2005-09 ,pp. : 791-806

Informa Healthcare

Access to resources Recommend Favorite